Skip to main content
. 2011 Jul 20;36(12):2529–2537. doi: 10.1038/npp.2011.141

Table 2. Continuous Performance Test Performance as a Function of Cannabis Use and AKT1 rs2494732 Genotype.

Cannabis use preceding onset of psychosis (n=601)a
  T/T
C/T
C/C
p interaction
  Never use (n=103) Use (n=107) Never use (n=125) Use (n=152) Never use (n=40) Use (n=74)  
CPT, accuracy (%) (SD) 92.6 (11.0) 94.4 (8.7) 95.3 (8.5) 95.4 (6.7) 94.4 (11.4) 91.6 (14.9) 0.003
CPT, reaction time (ms) (SD) 434.9 (76.9) 412.3 (79.5) 437.5 (87.5) 434.1 (82.5) 425.5 (84.7) 439.1 (92.2) 0.037
CPT, false alarms (n) (SD) 1.16 (4.2) 0.81 (3.4) 0.44 (0.8) 1.01 (4.9) 0.63 (1.4) 2.05 (7.0) 0.455
               
Cannabis use preceding onset of psychosis and absence of recent use (N=408)b
  T/T
C/T
C/C
p interaction
 
Never use (n=103)
Former use (n=51)
Never use (n=125)
Former use (n=64)
Never use (n=40)
Former use (n=25)
 
CPT, accuracy (%) (SD) 92.6 (11.0) 94.0 (8.3) 95.3 (8.5) 96.4 (6.3) 94.4 (11.4) 90.6 (16.7) 0.006
CPT, mean reaction time (ms) (SD) 434.9 (76.9) 423.5 (88.9) 437.5 (87.5) 429.8 (88.9) 425.5 (84.7) 467.1 (85.6) 0.044
a

Genotyping failed in 10 patients.

b

Patients without current use: reported no use of cannabis in the last year and urinalysis confirmed the absence of current cannabis use.